The use of oral vancomycin prophylaxis was associated with a significant decrease in the recurrence of Clostridium difficile infection, according to a poster presentation at the Interscience ...

Please provide your email address to receive an email when new articles are posted on . Fidaxomicin was the most rational fiscal strategy compared with vancomycin for Clostridium difficile-associated ...

Clostridioides difficile (C. difficile) is a leading cause of illness and death, especially for frail and hospitalized Americans. Now, a new study suggests that the leading antibiotic used to fight it ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO — Oral metronidazole was comparable to oral vancomycin in patients with Clostridium difficile infection ...

Treatment with ridinilazone was found to significantly decrease the rate of recurrent Clostridioides difficile infection (CDI) compared with vancomycin. Treatment with ridinilazone was found to ...

Clostridium difficile is the most common cause of nosocomial diarrhea in acute-care settings. Until now, the two available therapies for C. difficile-associated diarrhea (CDAD), vancomycin and ...

Researchers found that vancomycin is no longer superior to metronidazole; the change coincided with the emergence of a hypervirulent strain of C. difficile. Metronidazole and vancomycin have been the ...

C. difficile infection recurrence rates were numerically lower with vancomycin than with placebo, though the difference was not significant. However, the results could be clinically meaningful, an ...

Fidaxomicin should be the antibiotic of choice when treating adults with Clostridioides difficile infection, according to new guidance from the Infectious Diseases Society of America and the Society ...

Researchers conducted a phase II, randomized, double-blind, non-inferiority study including participants from 33 centers in the U.S. and Canada. The study includes patients with signs of C. diff ...

A study has linked initial vancomycin monotherapy to higher rates of Clostridium difficile infection in patients with inflammatory bowel disease, according to a report by Internal Medicine News. The ...

Fecal microbiota transplant was noninferior to vancomycin as the initial treatment for C. diff in a randomized, open-label trial. Transplant showed slightly higher cure rates without recurrence and ...